IN2015DN03947A - - Google Patents

Info

Publication number
IN2015DN03947A
IN2015DN03947A IN3947DEN2015A IN2015DN03947A IN 2015DN03947 A IN2015DN03947 A IN 2015DN03947A IN 3947DEN2015 A IN3947DEN2015 A IN 3947DEN2015A IN 2015DN03947 A IN2015DN03947 A IN 2015DN03947A
Authority
IN
India
Prior art keywords
argatroban
amino
methyl
sterile
aqueous
Prior art date
Application number
Other languages
English (en)
Inventor
Owoo George
A Burgos Richard
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of IN2015DN03947A publication Critical patent/IN2015DN03947A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3947DEN2015 2005-09-01 2006-08-28 IN2015DN03947A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71340305P 2005-09-01 2005-09-01
PCT/US2006/033432 WO2007027565A2 (fr) 2005-09-01 2006-08-28 Formulation d'argatroban

Publications (1)

Publication Number Publication Date
IN2015DN03947A true IN2015DN03947A (fr) 2015-10-02

Family

ID=37809398

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3947DEN2015 IN2015DN03947A (fr) 2005-09-01 2006-08-28

Country Status (22)

Country Link
US (3) US7642271B2 (fr)
EP (1) EP1948133B1 (fr)
JP (1) JP5189980B2 (fr)
KR (3) KR101753949B1 (fr)
CN (2) CN101257890B (fr)
AT (1) ATE514416T1 (fr)
AU (1) AU2006285097B2 (fr)
BR (1) BRPI0616127B8 (fr)
CA (1) CA2617920C (fr)
CY (1) CY1112109T1 (fr)
DK (1) DK1948133T3 (fr)
ES (1) ES2368758T3 (fr)
IL (2) IL189290A (fr)
IN (1) IN2015DN03947A (fr)
MX (1) MX2008002177A (fr)
NZ (1) NZ565821A (fr)
PL (1) PL1948133T3 (fr)
PT (1) PT1948133E (fr)
RU (1) RU2416393C2 (fr)
SI (1) SI1948133T1 (fr)
WO (1) WO2007027565A2 (fr)
ZA (1) ZA200802667B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101257890B (zh) * 2005-09-01 2012-10-31 巴克斯特国际公司 含有酸作为增溶剂的阿加曲班制剂
US7687516B2 (en) * 2006-09-27 2010-03-30 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US7589106B2 (en) 2006-09-27 2009-09-15 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US20100076019A1 (en) * 2006-10-11 2010-03-25 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US7915290B2 (en) 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
US20090221637A1 (en) * 2008-02-29 2009-09-03 Baxter International Inc. Solid-state salt argatroban formulations and methods for producing and using the same
CN101598725B (zh) * 2009-06-23 2012-07-18 南通大学附属医院 阿加曲班在血细胞和生化常规分析中的应用
LT2616064T (lt) 2010-10-21 2019-11-25 Rtu Pharmaceuticals Llc Parengtos naudoti ketorolako kompozicijos
CN102120026A (zh) * 2011-03-03 2011-07-13 天津市炜杰科技有限公司 以醇作为增溶剂的21(s)阿加曲班静脉注射液
CN102119922A (zh) * 2011-03-03 2011-07-13 天津市炜杰科技有限公司 以酸作为增溶剂的21(s)阿加曲班静脉注射液
CN102228677A (zh) * 2011-06-17 2011-11-02 天津市炜杰科技有限公司 以酸作为增溶剂的21(r)阿加曲班静脉注射液
TWI679977B (zh) * 2011-10-19 2019-12-21 大塚製藥股份有限公司 口服溶液
WO2017096298A1 (fr) * 2015-12-04 2017-06-08 Regents Of The University Of California Inhibiteurs d'histone désacétylase
CN107773533A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种新型凝血酶抑制剂及其制备方法
CN115381927A (zh) * 2022-09-20 2022-11-25 晓恩医药包装材料(安庆)有限公司 一种用于治疗缺血性脑梗塞的药物预灌装注射剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE420919B (sv) * 1973-08-13 1981-11-09 Mitsubishi Chem Ind Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
US5214052A (en) * 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
CA2091715A1 (fr) * 1992-03-18 1993-09-19 Mitsubishi Kasei Corporation Preparations d'argatroban pour usage ophtalmique
US5506241A (en) * 1992-03-18 1996-04-09 Mitsubishi Chemical Corporation Argatroban preparations for ophthalmic use
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
JPH06219948A (ja) 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
ATE177635T1 (de) 1993-04-22 1999-04-15 Senju Pharma Co Wässrige arzneizubereitungen enthaltend argatroban und cyclodextrin oder coffein
JPH07228532A (ja) * 1993-04-22 1995-08-29 Senju Pharmaceut Co Ltd 水性液剤、その有効成分の溶解性向上方法および安定化方法
US5998019A (en) * 1993-11-16 1999-12-07 Baxter International Inc. Multi-layered polymer structure for medical products
US5849843A (en) * 1993-11-16 1998-12-15 Baxter International Inc. Polymeric compositions for medical packaging and devices
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
JPH10316569A (ja) * 1997-05-19 1998-12-02 Mitsubishi Chem Corp アルガトロバンの可溶化方法及びそれによるアルガトロバン含有外用水性薬剤
KR101010547B1 (ko) * 2003-03-20 2011-01-24 미쓰비시 타나베 파마 코퍼레이션 알기닌아미드류를 함유하는 의약 제제
EP1648232A4 (fr) 2003-07-17 2009-12-30 Smithkline Beecham Corp Methode de traitement a l'argatroban pour des patients souffrant de thrombocytopenie induite par l'heparine
CN101257890B (zh) * 2005-09-01 2012-10-31 巴克斯特国际公司 含有酸作为增溶剂的阿加曲班制剂

Also Published As

Publication number Publication date
US20070049617A1 (en) 2007-03-01
KR20080042155A (ko) 2008-05-14
MX2008002177A (es) 2008-04-22
US20100099705A1 (en) 2010-04-22
JP5189980B2 (ja) 2013-04-24
PT1948133E (pt) 2011-08-01
JP2009507018A (ja) 2009-02-19
IL189290A0 (en) 2008-06-05
AU2006285097A1 (en) 2007-03-08
KR20150108430A (ko) 2015-09-25
CA2617920C (fr) 2014-05-27
US8034830B2 (en) 2011-10-11
HK1123193A1 (en) 2009-06-12
SI1948133T1 (sl) 2011-08-31
US20100099706A1 (en) 2010-04-22
HK1178053A1 (en) 2013-09-06
WO2007027565A3 (fr) 2007-10-04
IL189290A (en) 2011-10-31
US7985757B2 (en) 2011-07-26
BRPI0616127B8 (pt) 2021-05-25
RU2008112311A (ru) 2009-10-10
CY1112109T1 (el) 2015-11-04
ZA200802667B (en) 2009-01-28
ES2368758T3 (es) 2011-11-22
CN101257890B (zh) 2012-10-31
ATE514416T1 (de) 2011-07-15
NZ565821A (en) 2010-05-28
CN101257890A (zh) 2008-09-03
EP1948133A2 (fr) 2008-07-30
WO2007027565A2 (fr) 2007-03-08
CN102895179B (zh) 2014-10-22
BRPI0616127A2 (pt) 2011-06-07
CN102895179A (zh) 2013-01-30
EP1948133B1 (fr) 2011-06-29
AU2006285097B2 (en) 2011-08-18
RU2416393C2 (ru) 2011-04-20
PL1948133T3 (pl) 2012-03-30
KR101753949B1 (ko) 2017-07-04
KR20140009599A (ko) 2014-01-22
DK1948133T3 (da) 2011-10-03
BRPI0616127B1 (pt) 2020-05-12
CA2617920A1 (fr) 2007-03-08
US7642271B2 (en) 2010-01-05
IL208183A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
IN2015DN03947A (fr)
EA200700389A1 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
CN104812392B (zh) 稳定的培美曲塞制剂
CL2010000816A1 (es) Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06)
TN2009000317A1 (en) Solid preparation comprising alogliptin and pioglitazone
HUP0303278A2 (hu) Fagyasztva szárított pantoprazol készítmény, eljárás az előállítására és pantoprazol injekció
RU2012113844A (ru) Пероральные суспензионные лекарственные формы ацетата эсликарбазепина
NZ594055A (en) New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
EP1897452A3 (fr) Blanc d'oeuf déshydraté amélioré, son procédé de fabrication, et aliment contenant le blanc d'oeuf déshydraté amélioré
EP0336200B1 (fr) Compositions pharmaceutiques à base de piroxicame en solution aqueuse et procédé pour les préparer
JP2011502968A5 (fr)
WO2011016049A3 (fr) Composition stable pour injection de gemcitabine prête à l'emploi
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
WO2007005633A3 (fr) Procede de preparation d'une forme posologique liquide contenant du 4-phenylbutyrate de sodium
WO2003086324A3 (fr) Elaboration et utilisation d'une formulation stable de composes aux effets allosteriques
GEP20125525B (en) Stable liquid pharmaceutical composition based on trazodone
JP2009507018A5 (fr)
SI2094116T1 (sl) Trdni ali vodni alkalni pripravek ki obsega kreatinsko komponento postopek za njegovo pripravo innjegova uporaba
CH647759A5 (it) Derivato della glicina, metodo per la sua preparazione e composizioni farmaceutiche che lo contengono.
WO2010068181A8 (fr) Sel de citrate de 11-(2-pyrrolidin-1-yl-éthoxy)-14,19-dioxa-5,7,26-triaza-tétracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-décaène
RU2011109921A (ru) Препараты канфосфамида и их получения
WO2004004705A3 (fr) Formulations pharmaceutiques
WO2003094889A1 (fr) Produit de lyophilisation
UA85066C2 (ru) Способ приготавлевания транс- или цис-диаммонийдихлородигидроксоплатины (iv) и ее применение при получении фармацевтически активных веществ
WO2006002887A8 (fr) Solution a boire aqueuse d'indibuline (d-24851) et d'un acide organique